Table 2.
pT1a versus pT1b | pT1a and pT1b versus pT2a | pT1a, pT1b, and pT2a versus pT2b | |
---|---|---|---|
Odds ratio (95% CI) p value | Odds ratio (95% CI) p value | Odds ratio (95% CI) p value | |
94 versus 74 | 168 versus 43 | 211 versus 26 | |
Cases of each category | Cases of each category | Cases of each category | |
Cell type | 2.43 (0.85–6.89) 0.09 | 2.28 (0.76–6.82) 0.13 | 2.32 (0.84–6.36) 0.10 |
Clear versus others | 139 versus 29 | 175 versus 36 | 190 versus 47 |
Nuclear grade | 1.79 (0.57–5.56) 0.31 | 5.15 (1.87–14.2) 0.0015 | 3.39 (1.20–9.58) 0.020 |
Low versus high | 147 versus 21 | 176 versus 35 | 190 versus 47 |
MVI | 1.95 (0.92–4.16) 0.08 | 3.08 (1.47–6.48) 0.002 | 2.91 (1.19–7.11) 0.018 |
(−) versus (+) | 123 versus 45 | 144 versus 67 | 154 versus 83 |
MMP-2 | 1.14 (0.55–2.36) 0.71 | 2.13 (0.90–5.0) 0.84 | 1.24 (0.41–3.70) 0.70 |
Weak versus strong | 60 versus 108 | 76 versus 135 | 82 versus 156 |
MMP-9 | 1.79 (0.65–4.90) 0.205 | 1.47 (0.55–3.94) 0.43 | 1.31 (0.40–4.21) 0.64 |
Weak versus strong | 134 versus 34 | 163 versus 48 | 181 versus 56 |
TIMP-1 | 3.30 (1.32–8.26) 0.010 | 1.18 (0.43–3.26) 0.74 | 1.59 (0.49–5.10) 0.42 |
Weak versus strong | 31 versus 137 | 37 versus 174 | 42 versus 195 |
TIMP-2 | 1.41 (0.48–4.13) 0.53 | 2.14 (0.65–6.99) 0.84 | 3.03 (0.71–12.98) 0.13 |
Weak versus strong | 142 versus 26 | 178 versus 33 | 201 versus 36 |
MT-MMP-1 | 1.93 (0.65–5.71) 0.096 | 2.28 (0.76–3.50) 0.15 | 1.98 (0.60–6.54) 0.26 |
Weak versus strong | 144 versus 26 | 176 versus 35 | 194 versus 43 |
MVI: microvascular invasion.